AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer
Clinical trial NCT02380443 · COMPLETED
Trial details
- NCT number
- NCT02380443
- Sponsor
- Mirror Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-03-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.